BXRX =MC $52 M--FDA Decision in Q1 for attractive Drug

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
BXRX =MC $52 M--FDA Decision in Q1 for attractive Drug

An SI Board Since December 2019

Posts	SubjectMarks	Bans	Symbol
9	2	0	BXRX

Emcee: BioHero	Type: Moderated

Min Hr Day Wk Mon Yr 3 Yr Log

Introduction Market Data Compact

BXRX 0.0218

+7.4%

Feb 29 3:00 PM EDT

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
9	Still a massive buying opportunity at current laughable valuation of only $87 mi	BioHero	-	2/21/2020
8	17 days till FDA decision ,, still time to get in cheap	BioHero	-	2/3/2020
7	FDA approval is very likely this time ,, Approval would make this undiscovered s	BioHero	-	1/27/2020
6	Any dip here is a great buying opp ahead of the FDA decision next month ,stock l	BioHero	-	1/24/2020
5	FDA DECISION NEXT MONTH ...News out today (FDA) has set a PDUFA goal date of	BioHero	-	1/22/2020
4	Baudax Bio Inc. (BXRX) PT Raised to $12 at Oppenheimer streetinsider.com	BioHero	-	1/21/2020
3	GREAT buying opportunity here ahead of the NDA resubmission likely to hit the wi	BioHero	-	1/8/2020
2	NDA resubmission likely to come next week this will attract new investors so i t	BioHero	-	12/20/2019
1	massive upside potential on this undiscovered stock	BioHero	-	12/19/2019

Go to reply# or date (mm/dd/yy):